Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Nolan

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Vaccine|November 27, 2002
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccineTerry Nolan, Peter McIntyre, Don Roberton, et al.
Human Vaccines & Immunotherapeutics|June 28, 2019
Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adultsFederico Martinón-Torres, Terry Nolan, Daniela Toneatto, et al.
Frontiers in Immunology|August 1, 2022
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune ResponsesJoseph Torresi, Melissa A Edeling, Terry Nolan, et al.
Vaccines|May 25, 2024
The Platform Technology Approach to mRNA Product Development and RegulationJohn H Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccine|July 19, 2015
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adultsTerry Nolan, Miguel O'Ryan, James Wassil, et al.
Communicable Diseases Intelligence Quarterly Report|March 5, 2005
The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine useStephen Lambert, Kerry-Ann O'Grady, Susan Gabriel, et al.
Vaccines|October 28, 2025
Reactogenicity of an Inactivated, Split-Virion Quadrivalent Influenza Vaccine in Infants and Children Aged ≥6 Months to <9 YearsTerry Nolan, Frank R Albano, Janine Oberije, et al.
American Journal of Epidemiology|April 28, 2009
Optimal dosing and dynamic distribution of vaccines in an influenza pandemicJames Wood, James McCaw, Niels Becker, et al.
Australian and New Zealand Journal of Public Health|March 16, 2002
Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiativesLyndal Bond, Gabrielle Davie, John B Carlin, et al.
Influenza and Other Respiratory Viruses|December 9, 2010
Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective studyJodie McVernon, Karen Laurie, Ian Barr, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Vaccine|November 27, 2002
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccineTerry Nolan, Peter McIntyre, Don Roberton, et al.
Human Vaccines & Immunotherapeutics|June 28, 2019
Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adultsFederico Martinón-Torres, Terry Nolan, Daniela Toneatto, et al.
Frontiers in Immunology|August 1, 2022
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune ResponsesJoseph Torresi, Melissa A Edeling, Terry Nolan, et al.
Vaccines|May 25, 2024
The Platform Technology Approach to mRNA Product Development and RegulationJohn H Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccine|July 19, 2015
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adultsTerry Nolan, Miguel O'Ryan, James Wassil, et al.
Communicable Diseases Intelligence Quarterly Report|March 5, 2005
The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine useStephen Lambert, Kerry-Ann O'Grady, Susan Gabriel, et al.
Vaccines|October 28, 2025
Reactogenicity of an Inactivated, Split-Virion Quadrivalent Influenza Vaccine in Infants and Children Aged ≥6 Months to <9 YearsTerry Nolan, Frank R Albano, Janine Oberije, et al.
American Journal of Epidemiology|April 28, 2009
Optimal dosing and dynamic distribution of vaccines in an influenza pandemicJames Wood, James McCaw, Niels Becker, et al.
Australian and New Zealand Journal of Public Health|March 16, 2002
Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiativesLyndal Bond, Gabrielle Davie, John B Carlin, et al.
Influenza and Other Respiratory Viruses|December 9, 2010
Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective studyJodie McVernon, Karen Laurie, Ian Barr, et al.
Pageof 10